Jasper Therapeutics, Inc. (JSPR)
1.83
+0.04
(+2.23%)
USD |
NASDAQ |
Dec 31, 16:00
1.825
0.00 (0.00%)
After-Hours: 20:00
Jasper Therapeutics Free Cash Flow: -76.53M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cytokinetics, Inc. | -453.38M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
| Oragenics, Inc. | -8.429M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.00M |
| Cash from Financing (Quarterly) | 28.39M |
| Free Cash Flow Per Share (Quarterly) | -1.022 |
| Free Cash Flow to Equity (Quarterly) | -16.55M |
| Free Cash Flow to Firm (Quarterly) | -17.00M |
| Free Cash Flow Yield | -269.8% |